COVID-19 diagnostics and testing

FIND co-leads the diagnostic pillar of the Access to COVID-19 Tools (ACT) Accelerator.

Doctor making a test kit for viral disease COVID-19 nCoV. COVID-19 rapid test, 30.12.2020 © Celso Pupo Rodrigues/

COVID-19 testing worldwide

We have been tracking the development and commercialization of SARS-CoV-2 tests (immunoassays and molecular) for COVID-19, and compiled a fully searchable directory that includes performance data (sensitivity and specificity).

We also developed an interactive map that tracks the number of SARS-CoV-2 tests reported to have been performed in each country.

Country testing policies

This dashboard provides a global snapshot of COVID-19 country testing policies based on publicly available data and documents.

Genomic surveillance

Genomic surveillance is being increasingly used for SARS-CoV-2 to track and monitor the spread of variants and inform public health action.

External quality assessment (EQA) resources for COVID-19 testing

A critical component of laboratory quality management, which ensures that tests are performed accurately, results are comparable and reproducible, and errors are detected and corrected to avoid incorrect diagnosis.

FIND evaluations of SARS-CoV-2 assays

We are conducting independent evaluations of molecular tests and immunoassays, in collaboration with WHO and multiple partners worldwide, to assist in-country decision making.

Antigen rapid test implementation

Resources from FIND and partners to support implementation of antigen rapid tests in your country.

Online courses

Join our courses to get the latest recommendations on COVID-19 testing and up-to-date information on the performance of tests and how best to deploy them.

Find out how COVID-19 improved access to testing